PIRIA is being built for serious scientific work.
The goal is to help researchers and biotechnology teams work through complex oncology evidence without flattening the science into vague promises.
Why PIRIA
Modern oncology now spans molecular biology, imaging, pathology, therapeutic targeting, resistance mechanisms, spatial analysis and longitudinal monitoring. Valuable evidence exists across all of those layers, but it is fragmented and difficult to compare quickly.
PIRIA is being built to close that gap. The platform direction is intentionally research-first: keep the sources visible, state the uncertainty clearly and help users make faster, better-informed decisions.
What PIRIA is not
PIRIA is not a replacement for clinical judgment, laboratory validation or regulatory evidence. The public website is also not making a claim that PIRIA can diagnose cancer or choose treatment for a patient on its own.
Who it is for
PIRIA is being shaped for oncology researchers, translational teams, biotechnology companies and scientific partners who need structured, evidence-centered research intelligence.